Trial Outcomes & Findings for Peer-mentoring, Quality of Life and Caregiver Burden in Patients With Chronic Kidney Disease and Their Caregivers (NCT NCT02429115)

NCT ID: NCT02429115

Last Updated: 2019-12-13

Results Overview

The Kidney Disease Quality of Life-36 (KDQOL-36) score is the primary outcome measure. The KDQOL-36 contains 5 subscales: the Physical Component Summary (PCS), Mental Component Summary (MCS), Burden of Kidney Disease (BKD), Symptoms and Problems of Kidney Disease (SPKD), and Effects of Kidney Disease (EKD). The range for the sore of each domain is 0-100. Higher scores represent improved Quality of Life. Change in the scores of components of the KDQOL is the outcome variable of interest. We computed the slopes (rates of change in KDQOL subscales from baseline to 12 months and 18 months) using a random effects ANOVA (random intercept and random slope), and determined if the slopes were different using t-test.

Recruitment status

COMPLETED

Study phase

NA

Target enrollment

241 participants

Primary outcome timeframe

Measured at baseline, at 12 months and at 18 months, slope of change at 18 months reported.

Results posted on

2019-12-13

Participant Flow

Participant milestones

Participant milestones
Measure
Face-to-face Peer Mentoring Patients
Will receive 6 months of face-to-face peer mentoring by a trained peer mentor. Mentoring: Six months of peer-mentoring.
Online Peer Mentoring Patients
Will receive 6 months of online peer mentoring by a trained peer mentor. Mentoring: Six months of peer-mentoring.
Control Patients
Will not receive peer mentoring.
Face-to-face Peer Mentoring Caregivers
Will receive 6 months of face-to-face peer mentoring by a trained peer mentor. Mentoring: Six months of peer-mentoring.
Online Peer Mentoring Caregivers
Will receive 6 months of online peer mentoring by a trained peer mentor. Mentoring: Six months of peer-mentoring.
Control Caregivers
Will not receive peer mentoring.
Overall Study
STARTED
52
52
51
29
29
28
Overall Study
COMPLETED
40
42
35
21
22
27
Overall Study
NOT COMPLETED
12
10
16
8
7
1

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Peer-mentoring, Quality of Life and Caregiver Burden in Patients With Chronic Kidney Disease and Their Caregivers

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Face-to-face Peer Mentoring Patients
n=52 Participants
Will receive 6 months of face-to-face peer mentoring by a trained peer mentor. Mentoring: Six months of peer-mentoring.
Online Peer Mentoring Patients
n=52 Participants
Will receive 6 months of online peer mentoring by a trained peer mentor. Mentoring: Six months of peer-mentoring.
Control Patients
n=51 Participants
Will not receive peer mentoring.
Face-to-face Peer Mentoring Caregivers
n=29 Participants
Will receive 6 months of face-to-face peer mentoring by a trained peer mentor. Mentoring: Six months of peer-mentoring.
Online Peer Mentoring Caregivers
n=29 Participants
Will receive 6 months of online peer mentoring by a trained peer mentor. Mentoring: Six months of peer-mentoring.
Control Caregivers
n=28 Participants
Will not receive peer mentoring.
Total
n=241 Participants
Total of all reporting groups
Age, Customized
Age ≤ 47
11 Participants
n=5 Participants
18 Participants
n=7 Participants
15 Participants
n=5 Participants
7 Participants
n=4 Participants
11 Participants
n=21 Participants
8 Participants
n=8 Participants
70 Participants
n=8 Participants
Age, Customized
47< Age ≤ 54
14 Participants
n=5 Participants
10 Participants
n=7 Participants
12 Participants
n=5 Participants
7 Participants
n=4 Participants
5 Participants
n=21 Participants
6 Participants
n=8 Participants
54 Participants
n=8 Participants
Age, Customized
54 <Age ≤ 62
12 Participants
n=5 Participants
15 Participants
n=7 Participants
12 Participants
n=5 Participants
9 Participants
n=4 Participants
6 Participants
n=21 Participants
5 Participants
n=8 Participants
59 Participants
n=8 Participants
Age, Customized
62 < Age
15 Participants
n=5 Participants
9 Participants
n=7 Participants
12 Participants
n=5 Participants
6 Participants
n=4 Participants
7 Participants
n=21 Participants
9 Participants
n=8 Participants
58 Participants
n=8 Participants
Sex/Gender, Customized
Male
27 Participants
n=5 Participants
31 Participants
n=7 Participants
30 Participants
n=5 Participants
11 Participants
n=4 Participants
9 Participants
n=21 Participants
11 Participants
n=8 Participants
119 Participants
n=8 Participants
Sex/Gender, Customized
Female
25 Participants
n=5 Participants
21 Participants
n=7 Participants
21 Participants
n=5 Participants
18 Participants
n=4 Participants
20 Participants
n=21 Participants
17 Participants
n=8 Participants
122 Participants
n=8 Participants
Race/Ethnicity, Customized
White
24 Participants
n=5 Participants
26 Participants
n=7 Participants
24 Participants
n=5 Participants
13 Participants
n=4 Participants
13 Participants
n=21 Participants
14 Participants
n=8 Participants
114 Participants
n=8 Participants
Race/Ethnicity, Customized
Non-white
28 Participants
n=5 Participants
26 Participants
n=7 Participants
27 Participants
n=5 Participants
16 Participants
n=4 Participants
16 Participants
n=21 Participants
14 Participants
n=8 Participants
127 Participants
n=8 Participants
Ethnicity
Hispanic
5 Participants
n=5 Participants
5 Participants
n=7 Participants
7 Participants
n=5 Participants
2 Participants
n=4 Participants
4 Participants
n=21 Participants
2 Participants
n=8 Participants
25 Participants
n=8 Participants
Ethnicity
Non-Hispanic
47 Participants
n=5 Participants
47 Participants
n=7 Participants
44 Participants
n=5 Participants
27 Participants
n=4 Participants
25 Participants
n=21 Participants
26 Participants
n=8 Participants
216 Participants
n=8 Participants
Marital Status
Married
16 Participants
n=5 Participants
21 Participants
n=7 Participants
21 Participants
n=5 Participants
20 Participants
n=4 Participants
20 Participants
n=21 Participants
18 Participants
n=8 Participants
116 Participants
n=8 Participants
Marital Status
Not married
36 Participants
n=5 Participants
31 Participants
n=7 Participants
30 Participants
n=5 Participants
9 Participants
n=4 Participants
9 Participants
n=21 Participants
10 Participants
n=8 Participants
125 Participants
n=8 Participants
At least some college
Yes
22 Participants
n=5 Participants
30 Participants
n=7 Participants
25 Participants
n=5 Participants
11 Participants
n=4 Participants
12 Participants
n=21 Participants
9 Participants
n=8 Participants
109 Participants
n=8 Participants
At least some college
No
30 Participants
n=5 Participants
22 Participants
n=7 Participants
26 Participants
n=5 Participants
18 Participants
n=4 Participants
17 Participants
n=21 Participants
19 Participants
n=8 Participants
132 Participants
n=8 Participants
Employed
Employed
13 Participants
n=5 Participants
17 Participants
n=7 Participants
16 Participants
n=5 Participants
11 Participants
n=4 Participants
13 Participants
n=21 Participants
12 Participants
n=8 Participants
82 Participants
n=8 Participants
Employed
Not Employed
39 Participants
n=5 Participants
35 Participants
n=7 Participants
35 Participants
n=5 Participants
18 Participants
n=4 Participants
16 Participants
n=21 Participants
16 Participants
n=8 Participants
159 Participants
n=8 Participants
Rural
Rural
4 Participants
n=5 Participants
7 Participants
n=7 Participants
9 Participants
n=5 Participants
6 Participants
n=4 Participants
11 Participants
n=21 Participants
8 Participants
n=8 Participants
45 Participants
n=8 Participants
Rural
Urban
48 Participants
n=5 Participants
45 Participants
n=7 Participants
42 Participants
n=5 Participants
23 Participants
n=4 Participants
18 Participants
n=21 Participants
20 Participants
n=8 Participants
196 Participants
n=8 Participants

PRIMARY outcome

Timeframe: Measured at baseline, at 12 months and at 18 months, slope of change at 18 months reported.

Population: Patient participants.

The Kidney Disease Quality of Life-36 (KDQOL-36) score is the primary outcome measure. The KDQOL-36 contains 5 subscales: the Physical Component Summary (PCS), Mental Component Summary (MCS), Burden of Kidney Disease (BKD), Symptoms and Problems of Kidney Disease (SPKD), and Effects of Kidney Disease (EKD). The range for the sore of each domain is 0-100. Higher scores represent improved Quality of Life. Change in the scores of components of the KDQOL is the outcome variable of interest. We computed the slopes (rates of change in KDQOL subscales from baseline to 12 months and 18 months) using a random effects ANOVA (random intercept and random slope), and determined if the slopes were different using t-test.

Outcome measures

Outcome measures
Measure
Face-to-face Peer Mentoring Patients
n=52 Participants
Will receive 6 months of face-to-face peer mentoring by a trained peer mentor. Mentoring: Six months of peer-mentoring.
Online Peer Mentoring Patients
n=52 Participants
Will receive 6 months of online peer mentoring by a trained peer mentor. Mentoring: Six months of peer-mentoring.
Control Patients
n=51 Participants
Will not receive peer mentoring.
Slope of Change in Kidney Disease Quality of Life-36 Score
Effects of Kidney Disease
2.21 Scores on a scale / Months
Interval -1.1 to 5.52
4.13 Scores on a scale / Months
Interval 0.87 to 7.4
-0.50 Scores on a scale / Months
Interval -3.97 to 2.97
Slope of Change in Kidney Disease Quality of Life-36 Score
Burden of Kidney Disease
3.00 Scores on a scale / Months
Interval -1.27 to 7.27
5.44 Scores on a scale / Months
Interval 1.24 to 9.63
-0.99 Scores on a scale / Months
Interval -5.5 to 3.53
Slope of Change in Kidney Disease Quality of Life-36 Score
Short Form-12 Physical Composite
0.64 Scores on a scale / Months
Interval -0.94 to 2.22
2.50 Scores on a scale / Months
Interval 0.95 to 4.06
-0.70 Scores on a scale / Months
Interval -2.36 to 0.97
Slope of Change in Kidney Disease Quality of Life-36 Score
Short Form-12 Mental Composite Score
1.43 Scores on a scale / Months
Interval -0.28 to 3.13
3.46 Scores on a scale / Months
Interval 1.78 to 5.13
1.13 Scores on a scale / Months
Interval -0.66 to 2.92
Slope of Change in Kidney Disease Quality of Life-36 Score
Symptoms/Problems of Kidney Disease
3.41 Scores on a scale / Months
Interval -0.46 to 6.36
6.00 Scores on a scale / Months
Interval 3.09 to 8.91
-2.71 Scores on a scale / Months
Interval -6.2 to 0.78

PRIMARY outcome

Timeframe: Measured at baseline, at 12 months and at 18 months, slope of change at 18 months reported.

Population: Caregivers of patients with CKD

The Zarit caregiver Burden Interview (ZBI) score is the primary outcome measure. The score ranges between 0 and 88. Higher scores represent increased caregiver burden (worse outcome); smaller numbers indicate less caregiver burden (better outcome). Change in the ZBI score is the outcome variable of interest. We computed the slopes (rates of change in ZBI from baseline to 12 months and 18 months) using a random effects ANOVA (random intercept and random slope), and determined if the slopes were different using t-test.

Outcome measures

Outcome measures
Measure
Face-to-face Peer Mentoring Patients
n=29 Participants
Will receive 6 months of face-to-face peer mentoring by a trained peer mentor. Mentoring: Six months of peer-mentoring.
Online Peer Mentoring Patients
n=29 Participants
Will receive 6 months of online peer mentoring by a trained peer mentor. Mentoring: Six months of peer-mentoring.
Control Patients
n=28 Participants
Will not receive peer mentoring.
Slope of Change in Zarit Caregiver Burden Interview (ZBI) Score
-2.49 Scores on a scale / Months
Interval -5.85 to 0.87
-3.44 Scores on a scale / Months
Interval -6.31 to -0.57
-1.26 Scores on a scale / Months
Interval -4.06 to 1.54

SECONDARY outcome

Timeframe: Measured at baseline, at 12 months and at 18 months, slope of change at 18 months reported.

Population: Patient participants

The Patient Activation Measure (PAM) is the secondary outcome measure. The score ranges between 0-100. Higher scores represent improved patient activation and lower numbers indicate less patient activation. Change in the PAM is the outcome variable of interest. We computed the slopes ( rate of change in the PAM score from baseline to 12 months and 18 months) using a random effects ANOVA (random intercept and random slope), and determined if the slopes were different among the study groups using t-test.

Outcome measures

Outcome measures
Measure
Face-to-face Peer Mentoring Patients
n=52 Participants
Will receive 6 months of face-to-face peer mentoring by a trained peer mentor. Mentoring: Six months of peer-mentoring.
Online Peer Mentoring Patients
n=52 Participants
Will receive 6 months of online peer mentoring by a trained peer mentor. Mentoring: Six months of peer-mentoring.
Control Patients
n=51 Participants
Will not receive peer mentoring.
Slope of Change in Patient Activation Measure (PAM)
0.95 Scores on a scale / Months
Interval -1.96 to 3.86
5.66 Scores on a scale / Months
Interval 2.79 to 8.52
0.02 Scores on a scale / Months
Interval -3.03 to 3.08

Adverse Events

Face-to-face Peer Mentoring Patients

Serious events: 0 serious events
Other events: 0 other events
Deaths: 3 deaths

Online Peer Mentoring Patients

Serious events: 0 serious events
Other events: 0 other events
Deaths: 4 deaths

Control Patients

Serious events: 0 serious events
Other events: 0 other events
Deaths: 5 deaths

Face-to-face Peer Mentoring Caregivers

Serious events: 0 serious events
Other events: 0 other events
Deaths: 1 deaths

Online Peer Mentoring Caregivers

Serious events: 0 serious events
Other events: 0 other events
Deaths: 1 deaths

Control Caregivers

Serious events: 0 serious events
Other events: 0 other events
Deaths: 1 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Nasrollah Ghahramani

Penn State College of Medicine - Penn State Health

Phone: 7175318156

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place